Cargando…
15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival
A 15-LOX, it is proposed, suppresses the growth of prostate cancer in part by converting arachidonic, eicosatrienoic, and/or eicosapentaenoic acids to n-6 hydroxy metabolites. These metabolites inhibit the proliferation of PC3, LNCaP, and DU145 prostate cancer cells but only at ≥1–10 µM. We show her...
Autores principales: | O’Flaherty, Joseph T., Hu, Yungping, Wooten, Rhonda E., Horita, David A., Samuel, Michael P., Thomas, Michael J., Sun, Haiguo, Edwards, Iris J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447860/ https://www.ncbi.nlm.nih.gov/pubmed/23029040 http://dx.doi.org/10.1371/journal.pone.0045480 |
Ejemplares similares
-
Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer
por: O’Flaherty, Joseph T., et al.
Publicado: (2013) -
Lipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer
por: Chen, Kun-Ming, et al.
Publicado: (2021) -
Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils
por: Archambault, Anne-Sophie, et al.
Publicado: (2018) -
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword
por: Vaezi, Mohammad Amin, et al.
Publicado: (2021) -
Omega-3 Fatty Acids and PPARγ in Cancer
por: Edwards, Iris J., et al.
Publicado: (2008)